James Hector E, Bradley John S
Lucy Gooding Pediatric Neurosurgery Center, University of Florida HSC/Jacksonville and Wolfson Children's Hospital, Jacksonville, FL 32207, USA.
Pediatr Neurosurg. 2008;44(2):104-11. doi: 10.1159/000113111. Epub 2008 Jan 24.
This report is limited to patients with a single cerebrospinal fluid (CSF) shunt infected by a single organism, and compares two treatment protocols.
In the initial protocol (1975-1991), patients underwent removal of the shunt system and received intravenous and intraventricular antibiotics. Intraventricular antibiotics were administered twice daily to those with external ventricular drainage. When CSF was cultured 48 h off all antibiotics and found to be sterile at 24 h of incubation, a new shunt was inserted. Follow-up CSF cultures were obtained in all patients between 1-6 months following placement of the new shunt.
There were 25 patients (ages 1 month to 16 years; mean +/- SD: 23 +/- 4.0 months). CSF obtained from the shunt yielded the following: Staphylococcus epidermidis (19), Staphylococcus aureus (2), Streptococcus species (2), Serratia marcescens (1), and Propionebacterium species (1). The duration of intravenous antibiotics was 7-12 days (mean +/- SD: 9.7 +/- 1.3 days), and intraventricular antibiotic therapy was 6.2 +/- 1.7 days. Total hospital stay was 15.2 +/- 2.3 days. The follow-up period was 7.7 +/- 3.6 years. Following the initial protocol in another 15 patients (1992-2004), the treatment regime was modified in that intraventricular antibiotics were administered once daily in patients with external ventricular drainage, and the CSF was cultured at 24 h off antibiotics, instead of 48 h. Results were similar to the initial protocol with respect to days of antibiotic therapy and hospital stay.
Based on our retrospective nonrandomized series, we believe patients with a single shunt and noncompartmentalized hydrocephalus can be successfully treated without a prolonged antibiotic course and lengthy hospital stay.
本报告仅限于由单一微生物感染单一脑脊液(CSF)分流管的患者,并比较两种治疗方案。
在初始方案(1975 - 1991年)中,患者接受分流系统移除,并接受静脉和脑室内抗生素治疗。对于行体外脑室引流的患者,脑室内抗生素每日给药两次。当停用所有抗生素48小时后采集的脑脊液在培养24小时时无菌,插入新的分流管。在植入新分流管后的1 - 6个月内,对所有患者进行随访脑脊液培养。
共有25例患者(年龄1个月至16岁;平均±标准差:23±4.0个月)。从分流管获取的脑脊液培养结果如下:表皮葡萄球菌(19例)、金黄色葡萄球菌(2例)、链球菌属(2例)、粘质沙雷氏菌(1例)和丙酸杆菌属(1例)。静脉使用抗生素的持续时间为7 - 12天(平均±标准差:9.7±1.3天),脑室内抗生素治疗时间为6.2±1.7天。总住院时间为15.2±2.3天。随访期为7.7±3.6年。在另外15例患者中(1992 - 2004年)采用初始方案,治疗方案有所修改,即对于行体外脑室引流的患者,脑室内抗生素每日给药一次,并且在停用抗生素24小时时采集脑脊液进行培养,而非48小时。在抗生素治疗天数和住院时间方面,结果与初始方案相似。
基于我们的回顾性非随机系列研究,我们认为单一分流管且非分隔性脑积水的患者无需延长抗生素疗程和长时间住院即可成功治疗。